Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 6, 2014
Patent Application Number
12557832
Date Filed
September 11, 2009
Patent Citations Received
0
Patent Primary Examiner
Patent abstract
Eye diseases such as glaucoma can be treated using a composition containing cross-linked hyaluronic acid or a cross-linked salt of hyaluronic acid such as sodium hyalurate. The composition can be a monophasic gel. The composition can include a cross-linking agent such as 1,4-butanediol diglycidylether. The composition can contains about 2.25% (w/w) of the salt of hyaluronic acid. The composition can have a cross-linking rate of about 0.5 to 50%.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
